Výsledky vyhledávání - "M. C. Barthet"

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Common Risk Factors Add to Inherited Thrombophilia to Predict Venous Thromboembolism Risk in Families

Autor: Dominique Brunet, Noémie Resseguier, Noémie Saut, M. C. Barthet, Manal Ibrahim, David A. Tregouet, Alexia Robin, Geoffroy Venton, Pierre Suchon, Pierre Morange, Marie-Christine Alessi

Publikováno v: TH Open
TH Open, 2019, 03 (01), pp.e28-e35. ⟨10.1055/s-0039-1677807⟩
TH Open, Vol 03, Iss 01, Pp e28-e35 (2019)
TH Open: Companion Journal to Thrombosis and Haemostasis

International audience; The clinical venous thromboembolism (VTE) pattern often shows wide heterogeneity within relatives of a VTE-affected family, although they carry the same thrombophilia defect. It is then mandatory to develop additional tools fo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0e5575021ad9fb423925efba4a38da8
https://hal-amu.archives-ouvertes.fr/hal-02267213/document

Zobrazit plný text záznamu

Risk factors for venous thromboembolism in women under combined oral contraceptive. The PILl Genetic RIsk Monitoring (PILGRIM) Study

Autor: Marie-Christine Alessi, David-Alexandre Trégouët, Agathe Henneuse, Fadi Al Frouh, Pierre-Emmanuel Morange, Pierre Suchon, Manal Ibrahim, Dominique Brunet, Geoffroy Venton, Marie-Françoise Aillaud, M. C. Barthet

Publikováno v: Thrombosis and Haemostasis
Thrombosis and Haemostasis, Schattauer, 2016, 115 (1), pp.135-42. ⟨10.1160/TH15-01-0045⟩
Thrombosis and Haemostasis, 2016, 115 (1), pp.135-42. ⟨10.1160/TH15-01-0045⟩

SummaryIdentifying women at risk of venous thromboembolism (VTE) is a major public health issue. The objective of this study was to identify environmental and genetic determinants of VTE risk in a large sample of women under combined oral contracepti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52086b768e801cfb5a841a477c4e22c2
https://hal.archives-ouvertes.fr/hal-01478140

Zobrazit plný text záznamu

Risk assessment of venous thrombosis in families with known hereditary thrombophilia: the MARseilles-NImes prediction model

Autor: Pierre Morange, Marie-Christine Alessi, M. C. Barthet, Sophie Bouvet, William Cohen, David-Alexandre Trégouët, Christel Castelli, Pierre Suchon, Dominique Brunet, M.F. Aillaud

Publikováno v: Journal of thrombosis and haemostasis : JTH. 12(2)

Summary Background Although predicting the risk of venous thrombosis (VT) in an individual from a family with inherited thrombophilia is of major importance, it is often not feasible. Objectives To develop a simple risk assessment model that improves

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cafd9725119a5fef4c4838acf9609946
https://pubmed.ncbi.nlm.nih.gov/24738120

Zobrazit plný text záznamu

Screening for Identified and Unidentified Protein C Pathway Defects by theAgkistrodon contortrixVenom Test in Consecutive Patients

Autor: A. Robert, E Verdy, P.E. Morange, V Eschwège, M. C. Barthet, I. Juhan-Vague, M F Aillaud

Publikováno v: American Journal of Clinical Pathology. 112:233-237

To determine the real performance of the Agkistrodon contortrix venom (ACV) screening test for protein C (PC) pathway defects, we studied 400 consecutive patients referred for the study of personal venous thrombosis or for family study. All 82 patien

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77186e16356045714aec54b6741e76b6
https://doi.org/10.1093/ajcp/112.2.233

Zobrazit plný text záznamu

Exercices de médecine de catastrophe: intérêt d'une fiche de simulation évolutive pour les victimes

Autor: M. C. Barthet, V. Coste, B. Joly, C. Virenque, F Vuillermoz

Publikováno v: Médecine de Catastrophe - urgences collectives. 1:29-32

Resume Au cours du dernier exercice pratique sanctionnant la capacite de medecine de catastrophe a Toulouse, nous avons teste une nouvelle modalite de simulation pour les victimes en utilisant une fiche plastron evolutive. L'objectif de cette fiche e

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d94188a8f85ef8cb51670a52dbaed9e8
https://doi.org/10.1016/s1279-8479(98)80012-8

Zobrazit plný text záznamu

ABO blood group and von Willebrand factor levels partially explained the incomplete penetrance of congenital thrombophilia

Autor: Marie-Christine Alessi, Noémie Saut, David-Alexandre Trégouët, William Cohen, Géraldine Lavigne, Sophie Bouvet, Christel Castelli, Pierre-Emmanuel Morange, Dominique Brunet, Marie-Françoise Aillaud, M. C. Barthet

Publikováno v: Arteriosclerosis, thrombosis, and vascular biology. 32(8)

Objective— We aimed to study the association among ABO blood group, von Willebrand factor, factor VIII plasma levels, and the risk of venous thrombosis (VT) in a cohort of 1774 relatives from 500 families with inherited thrombophilia. Methods and R

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b22a3b9802be43e6eee6b2b7c82b658f
https://pubmed.ncbi.nlm.nih.gov/22628432

Zobrazit plný text záznamu

Maladie thromboembolique veineuse sous contraceptifs oraux combinés : impact des facteurs génétiques et environnementaux

Autor: D. Brunet, M. F. Aillaud, M. C. Barthet, Pierre Suchon, Pierre Morange, Marie-Christine Alessi, G. Sarlon

Publikováno v: Journal des Maladies Vasculaires. 39:333

Introduction L’incidence de la maladie thromboembolique veineuse (MTEV) chez les femmes en âge de procreer est faible, mais certains facteurs majorent ce risque. Parmi eux, les contraceptifs oraux combines (COC) sont largement distribues et sont r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::05ab954587fb879c253a6415b67add4b
https://doi.org/10.1016/j.jmv.2014.07.055

Zobrazit plný text záznamu

Prévalence des maladies cardiovasculaires chez 42 patients traités par Nilotinib pour une leucémie myéloïde chronique

Autor: M. C. Barthet, Pierre Morange, Raphael Soler, Jean-Michel Bartoli, M. Carcopino-Tusoli, Gabrielle Sarlon-Bartoli, A. Charbonnier, Michel A. Bartoli, D. Brunet, William Cohen

Publikováno v: Journal des Maladies Vasculaires. 39:329

Introduction Le traitement de la leucemie myeloide chronique (LMC) a connu une revolution avec la decouverte des inhibiteurs des tyrosines kinases (ITK) (imatinib/Glivec®). En 2007, deux nouvelles molecules, Nilotinib (Tasigna®) et Dasatinib (Spryc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d2372bebcf922fa3b55ad3ea2a587dae
https://doi.org/10.1016/j.jmv.2014.07.046

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání